Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst's FDA approval and implications.
Gut Microbes. 2023 Jan-Dec;15(1):2232137. doi: 10.1080/19490976.2023.2232137.
Gut Microbes. 2023.
PMID: 37431860
Free PMC article.
Corrigendum to "The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2)" [Biochem. Pharmacol. 194 (2021) 114840].
Sutter ML, Console L, Fahner AF, Samodelov SL, Gai Z, Ciarimboli G, Indiveri C, Kullak-Ublick GA, Visentin M.
Sutter ML, et al. Among authors: fahner af.
Biochem Pharmacol. 2022 Jul;201:115100. doi: 10.1016/j.bcp.2022.115100. Epub 2022 May 26.
Biochem Pharmacol. 2022.
PMID: 35635891
Free article.
No abstract available.
Item in Clipboard
The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2).
Sutter ML, Console L, Fahner AF, Samodelov SL, Gai Z, Ciarimboli G, Indiveri C, Kullak-Ublick GA, Visentin M.
Sutter ML, et al. Among authors: fahner af.
Biochem Pharmacol. 2021 Dec;194:114840. doi: 10.1016/j.bcp.2021.114840. Epub 2021 Nov 11.
Biochem Pharmacol. 2021.
PMID: 34774844
Free article.
Item in Clipboard
Cite
Cite